|
Sign In to gain access to subscriptions and/or personal tools.
|
Dissociable Effects of a Single Dose of Ecstasy (MDMA) on Psychomotor Skills and Attentional Performance
C. T. J. Lamers
c.lamers{at}psychology.unimaas.nl
J. G. Ramaekers
N. D. Muntjewerff
K. L. Sikkema
W. J. Riedel
Experimental Psychopharmacology Unit, Brain and Behaviour Institute, Maastricht University, Maastricht, The Netherlands
N. Samyn
National Institute of Criminalistics and Criminology, Section Toxicology, Brussels, Belgium
N. L. Read
Institute for Transport Studies, University of Leeds, UK
K. A. Brookhuis
Department of Psychology, University of Groningen, The Netherlands
Ecstasy (3,4-methylenedioxymethamphetamine, MDMA) is a psychoactive recreational drug widely used by young people visiting dance parties, and has been associated with poor cognitive function. The current study assessed the influence of a single dose of MDMA 75 mg and alcohol 0.5 g/kg on cognition, psychomotor performance and driving-related task performance. Twelve healthy recreational ecstasy users participated in an experimental study conducted according to a double-blind, double-dummy, placebo-controlled three-way cross-over design. MDMA improved psychomotor performance, such as movement speed and tracking performance in a single task, as well as in a divided attention task. MDMA impaired the ability to predict object movement under divided attention. However, the inability to accurately predict object movement after MDMA may indicate impairment of particular performance skills relevant to driving. There was no effect of MDMA on visual search, planning or retrieval from semantic memory.
Key Words: alcohol cognition ecstasy MDMA psychomotor performance traffic safety
Journal of Psychopharmacology, Vol. 17, No. 4,
379-387 (2003)
DOI: 10.1177/0269881103174015

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
K. Kuypers, M. Wingen, and J. Ramaekers
Memory and mood during the night and in the morning after repeated evening doses of MDMA
J Psychopharmacol,
November 1, 2008;
22(8):
895 - 903.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
A. C. Parrott, I. S. McGregor, T. M. C. Lee, A. B. Scholey, and M. J. Morgan
International conference on memory (ICOM-4), University of New South Wales, Sydney, Australia, 16 21 July 2006 Ecstasy/MDMA and Memory Symposium
J Psychopharmacol,
November 1, 2007;
21(8):
895 - 897.
[PDF]
|
 |
|

|
 |

|
 |
 
A. C. Parrott
MDMA in humans: factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress
J Psychopharmacol,
March 1, 2006;
20(2):
147 - 163.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
G. J. H. Dumont and R. J. Verkes
A review of acute effects of 3,4-methylenedioxymethamphetamine in healthy volunteers
J Psychopharmacol,
March 1, 2006;
20(2):
176 - 187.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
F. T. Peters, N. Samyn, C. T.J. Lamers, W. J. Riedel, T. Kraemer, G. de Boeck, and H. H. Maurer
Drug Testing in Blood: Validated Negative-Ion Chemical Ionization Gas Chromatographic-Mass Spectrometric Assay for Enantioselective Measurement of the Designer Drugs MDEA, MDMA, and MDA and Its Application to Samples from a Controlled Study with MDMA
Clin. Chem.,
October 1, 2005;
51(10):
1811 - 1822.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. C. Parrott
Chronic tolerance to recreational MDMA (3,4-methylenedioxymethamphetamine) or Ecstasy
J Psychopharmacol,
January 1, 2005;
19(1):
71 - 83.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
A. C. Parrott, E. Gouzoulis-Meyfrank, J. Rodgers, and N. Solowij
Ecstasy/MDMA and cannabis: the complexities of their interactive neuropsychobiological effects
J Psychopharmacol,
December 1, 2004;
18(4):
572 - 576.
[PDF]
|
 |
|
|
|